EDGC Healthcare, a subsidiary of the global genome precision medicine company, Wonwon Agnonomics (hereafter EDGC), announced that the US state governments such as New York, Nevada and California have signed LOI for 1 million corona19 diagnostic reagents from affiliates, Solgent.
EDGC Healthcare said, “Corona infections are spreading rapidly in many states in the United States.” “We will supply large-scale reagents through the EDGC global network to contribute to the early termination of the pandemic situation in 194 countries, including the United States.” .
On the other hand, Yoo Jae-hyung, CEO of Solgent, an affiliate of EDGC, presented the opinion on the global crisis by attending an invitational meeting for the diagnosis kit of the new coronavirus infection (Corona 19) morning (25th). .
At the meeting, President Moon Jae-in praised the efforts of the officials in the diagnostic reagents industry, who played a role in the construction of the Korean defense system, and listened to the explanation of the process of producing and developing diagnostic reagents and the approval status of the emergency use of diagnostic reagents.
President Moon also had a meeting with four representatives including Solgent, who was approved for emergency use of diagnostic reagents. Here, Yoo Jae-hyung, △ Simplified the process of reporting changes due to the expansion of GMP factories and supported production-related equipment and facilities △ Requested full support from the government for approval of each country such as US FDA approval △ Through K-BIO's national branding It suggested the government's support for the competitiveness of domestic equipment and technology.
Reporter Moon Se-young email@example.com
Copyrightⓒ 'Honest knowledge for health' Comedy.com (http://kormedi.com) / Unauthorized reproduction-Redistribution prohibited